Lest we forget11 Feb 2019 08:42
Over 20,000 deaths in the US every year from resistant ABs.
Iclaprim - non resistant AB - they way it works in the unique selling point..
What are the hospitals going to use? And what will happen to them if they don't?
For once on AIM thinking big is not divorced from reality.
And sales will be global - not just the initial US market..
High margin, patent protected for decades.
Enough from me - gotta work it out for yourself.